QQQ   393.25 (+0.28%)
AAPL   192.60 (-1.59%)
MSFT   368.11 (-1.64%)
META   324.36 (-2.52%)
GOOGL   132.61 (-1.76%)
AMZN   144.32 (-2.10%)
TSLA   241.60 (-0.92%)
NVDA   467.79 (-1.53%)
NIO   7.46 (+1.08%)
BABA   70.98 (-1.61%)
AMD   131.82 (+2.25%)
T   16.63 (-1.71%)
F   11.04 (+0.27%)
MU   77.31 (+3.14%)
CGC   0.77 (-4.13%)
GE   119.71 (-0.73%)
DIS   92.51 (-0.33%)
AMC   6.77 (-2.31%)
PFE   28.56 (-0.76%)
PYPL   59.01 (+0.12%)
XOM   99.10 (-0.45%)
QQQ   393.25 (+0.28%)
AAPL   192.60 (-1.59%)
MSFT   368.11 (-1.64%)
META   324.36 (-2.52%)
GOOGL   132.61 (-1.76%)
AMZN   144.32 (-2.10%)
TSLA   241.60 (-0.92%)
NVDA   467.79 (-1.53%)
NIO   7.46 (+1.08%)
BABA   70.98 (-1.61%)
AMD   131.82 (+2.25%)
T   16.63 (-1.71%)
F   11.04 (+0.27%)
MU   77.31 (+3.14%)
CGC   0.77 (-4.13%)
GE   119.71 (-0.73%)
DIS   92.51 (-0.33%)
AMC   6.77 (-2.31%)
PFE   28.56 (-0.76%)
PYPL   59.01 (+0.12%)
XOM   99.10 (-0.45%)
QQQ   393.25 (+0.28%)
AAPL   192.60 (-1.59%)
MSFT   368.11 (-1.64%)
META   324.36 (-2.52%)
GOOGL   132.61 (-1.76%)
AMZN   144.32 (-2.10%)
TSLA   241.60 (-0.92%)
NVDA   467.79 (-1.53%)
NIO   7.46 (+1.08%)
BABA   70.98 (-1.61%)
AMD   131.82 (+2.25%)
T   16.63 (-1.71%)
F   11.04 (+0.27%)
MU   77.31 (+3.14%)
CGC   0.77 (-4.13%)
GE   119.71 (-0.73%)
DIS   92.51 (-0.33%)
AMC   6.77 (-2.31%)
PFE   28.56 (-0.76%)
PYPL   59.01 (+0.12%)
XOM   99.10 (-0.45%)
QQQ   393.25 (+0.28%)
AAPL   192.60 (-1.59%)
MSFT   368.11 (-1.64%)
META   324.36 (-2.52%)
GOOGL   132.61 (-1.76%)
AMZN   144.32 (-2.10%)
TSLA   241.60 (-0.92%)
NVDA   467.79 (-1.53%)
NIO   7.46 (+1.08%)
BABA   70.98 (-1.61%)
AMD   131.82 (+2.25%)
T   16.63 (-1.71%)
F   11.04 (+0.27%)
MU   77.31 (+3.14%)
CGC   0.77 (-4.13%)
GE   119.71 (-0.73%)
DIS   92.51 (-0.33%)
AMC   6.77 (-2.31%)
PFE   28.56 (-0.76%)
PYPL   59.01 (+0.12%)
XOM   99.10 (-0.45%)

Mainz Biomed (MYNZ) Stock Forecast & Price Target

$1.08
-0.04 (-3.14%)
(As of 09:56 AM ET)
Compare
Today's Range
$1.08
▼
$1.11
50-Day Range
$1.08
▼
$3.15
52-Week Range
$1.03
▼
$8.21
Volume
12,226 shs
Average Volume
101,775 shs
Market Capitalization
$12.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.33
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media

Mainz Biomed Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 3 Analyst Ratings

Analysts' Consensus Price Target

$8.33
671.60% Upside
High Forecast$11.00
Average Forecast$8.33
Low Forecast$5.00
TypeCurrent Forecast
12/11/22 to 12/11/23		1 Month Ago
11/11/22 to 11/11/23		3 Months Ago
9/12/22 to 9/12/23		1 Year Ago
12/11/21 to 12/11/22
Consensus Rating
Moderate Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$8.33$9.67$9.00$20.00
Predicted Upside671.60% Upside124.46% Upside111.27% Upside138.38% Upside
Get Mainz Biomed Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter.


MYNZ Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MYNZ Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Mainz Biomed Stock vs. The Competition

TypeMainz BiomedMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.67
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside647.38% Upside733.17% Upside13.58% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/21/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		R. Osborn
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOverweight ➝ Neutral
11/20/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$9.00 ➝ $5.00+313.22%
2/10/2023Jonestrading
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$11.00+66.67%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 10:15 AM ET.












MYNZ Price Target - Frequently Asked Questions

What is Mainz Biomed's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Mainz Biomed stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for MYNZ. The average twelve-month price prediction for Mainz Biomed is $8.33 with a high price target of $11.00 and a low price target of $5.00. Learn more on MYNZ's analyst rating history.

Do Wall Street analysts like Mainz Biomed more than its competitors?

Analysts like Mainz Biomed less than other Medical companies. The consensus rating score for Mainz Biomed is 2.67 while the average consensus rating score for medical companies is 2.67. Learn more on how MYNZ compares to other companies.

Is Mainz Biomed being downgraded by Wall Street analysts?

Over the previous 90 days, Mainz Biomed's stock had 1 downgrade by analysts.

Does Mainz Biomed's stock price have much upside?

According to analysts, Mainz Biomed's stock has a predicted upside of 121.16% based on their 12-month stock forecasts.

What analysts cover Mainz Biomed?

Mainz Biomed has been rated by Cantor Fitzgerald, and HC Wainwright in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:MYNZ) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -